The business focus of Apodemus in pharmaceutical development is in virus induced infections causing diseases with an unmet medical need.
We employ a rational design for the development of novel antiviral treatments. Our research and development portfolio comprises several projects in different stages of development. The most advanced project entered Clinical phase during 2013.
Apodemus research and development organization is small and we work closely together with external contract research organizations (CROs).